Insmed Incorporated Hits New 52-Week High at $16.20 (INSM)
Shares of Insmed Incorporated (NASDAQ:INSM) hit a new 52-week high on Thursday, AR Network reports. The company traded as high as $16.20 and last traded at $16.09, with a volume of 541,159 shares trading hands. The stock had previously closed at $14.95.
A number of research firms have recently commented on INSM. Analysts at Leerink Swann reiterated an “outperform” rating on shares of Insmed Incorporated (NASDAQ:INSM) in a research note to investors on Wednesday, August 28th. Analysts at UBS AG reiterated a “buy” rating on shares of Insmed Incorporated (NASDAQ:INSM) in a research note to investors on Tuesday, June 18th. They now have a $17.50 price target on the stock.
Four investment analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of $20.75.
Insmed Incorporated has a 1-year low of $3.35 and a 1-year high of $16.00. The stock’s 50-day moving average is $12.55 and its 200-day moving average is $10.26. The company’s market cap is $620.3 million.
Insmed Incorporated (NASDAQ:INSM) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.04. Analysts expect that Insmed Incorporated will post $-1.57 EPS for the current fiscal year.
Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical company specializing in recombinant protein drug development.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.